Mental Health in Autistic Adults: An RDoC Approach
成人自闭症患者的心理健康:RDoC 方法
基本信息
- 批准号:10698092
- 负责人:
- 金额:$ 54.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-06 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAdultAdverse eventAgeAgingAlgorithmsAnxietyAppointmentAttention deficit hyperactivity disorderBiological MarkersBrainClinicalClinical DataCollaborationsCommunicationCommunitiesConsentCrisis InterventionDataDiagnosisDiagnosticDifferential DiagnosisDimensionsDocumentationElderlyElectronic MailEnrollmentEnsureEthnic OriginFeeling suicidalFemaleFundingFunding MechanismsGoalsGrantHealth PersonnelIndividualIntellectual functioning disabilityLeadMachine LearningMeasuresMental DepressionMental HealthMethodsMinorityMonitorNewsletterParticipantPersonality DisordersPersonsPhenotypeProbabilityProceduresProcessProductivityProtocols documentationPsychiatric DiagnosisRaceRecording of previous eventsRecruitment ActivityRegistriesReportingResearchResearch Domain CriteriaResearch PersonnelResearch Project GrantsResourcesRiskRuralSafetyScheduleServicesStructureSuicideSymptomsSystemTimeTrainingUncertaintyUnited States National Institutes of HealthUpdateVisitadult with autism spectrum disorderage relatedautism spectrum disorderautisticcognitive testingcohortethnic identityexperiencehuman old age (65+)inclusion criteriaindexinginnovationmarginalizationmarginalized populationmeetingsnovelparticipant retentionphenotypic datapredictive modelingprogramsracial identityrecruitresponsesatisfactionscreeningservice interventionsexsuccesssuicidalsuicidal behaviorsuicidal risktheoriestool
项目摘要
Clinical Core Abstract
The purpose of the Clinical Core is 1): To manage recruitment activities and consent and enroll a Pittsburgh
ACE Cohort for participation in the three Projects. We will prioritize increased participation by individuals
traditionally minoritized in ASD research (e.g., race/ethnicity, LGBTQIA+, females, and diagnosis of ASD in
adulthood); 2): Administer, score, and enter data for ASD diagnostic assessments and administer all RFA-
required and center-wide phenotypic measures; 3) Apply a novel posterior probability of diagnosis (PPOD)
index to estimate the presence of psychiatric diagnoses and ASD; 4) Establish age-related variables for use
across Projects, including a biomarker of brain age and documentation of age of ASD diagnosis; 5) Manage
scheduling of participants for all Projects. 6) Support retention of participants and monitor progress through
Projects; 7) Monitor risks related to suicidality and other adverse events, and 8) To collaborate with other
Cores and Projects. The Core will enroll 200 autistic and 100 non-autistic 18- to 65-year-old adults (>50 in
each group with a recent history of suicidal ideation or behaviors [SI/SB], defined as active SI/SB within the
past four months). We anticipate needing to consent and assess approximately 100 additional individuals to
account for those who do not meet inclusion criteria. Those meeting study inclusion criteria will be invited to
participate in all three Projects. Our team has consistently met recruitment goals for numerous NIH-funded
studies of autistic adults, we have active partnerships with several registries for autistic and non-autistic adults,
and we will collaborate with the Dissemination and Partnership Core to enhance our inclusion of autistic adults
from groups that have been marginalized. The Clinical Core organizes the extensive recruitment effort to
assure the Projects meet their targeted enrollments and complete their proposed studies, while assuring all the
data mandated by the ACE funding mechanism is collected. The centralization of these services in a Core
combines the recruitment resources that would otherwise be distributed across Projects, thereby reducing the
redundancy and inefficiency that would occur if each Project had to perform these efforts individually.
Research-reliable Clinical Core staff will conduct ASD diagnostic and cognitive assessments using the tools
outlined in the RFA; this also creates an efficient process and supports the collaboration of investigators new to
autism in this ACE center. Finally, Clinical Core staff are highly experienced in the assessment of SI/SB and
psychiatric diagnoses and will monitor for suicide-related risks.
临床核心摘要
临床核心的目的是 1):管理招募活动和同意并注册匹兹堡
参与这三个项目的 ACE 队列。我们将优先考虑增加个人的参与
传统上,自闭症谱系障碍 (ASD) 研究中的少数群体(例如,种族/族裔、LGBTQIA+、女性以及自闭症谱系障碍的诊断)
成年); 2):管理、评分和输入 ASD 诊断评估数据,并管理所有 RFA-
所需的和中心范围内的表型测量; 3)应用新的后验诊断概率(PPOD)
评估是否存在精神疾病和自闭症谱系障碍的指数; 4)建立与年龄相关的变量以供使用
跨项目,包括大脑年龄的生物标志物和 ASD 诊断年龄的记录; 5)管理
所有项目的参与者的安排。 6) 支持保留参与者并通过以下方式监控进度
项目; 7) 监控与自杀和其他不良事件相关的风险,以及 8) 与其他人合作
核心和项目。核心将招收 200 名自闭症患者和 100 名非自闭症 18 至 65 岁成年人(> 50 岁)
每个近期有自杀意念或行为史的群体[SI/SB],定义为活跃的SI/SB
过去四个月)。我们预计需要另外约 100 名个人同意并进行评估
考虑那些不符合纳入标准的人。那些符合研究纳入标准的人将被邀请
参与所有三个项目。我们的团队始终如一地实现了众多 NIH 资助的招募目标
对成人自闭症的研究,我们与多个自闭症和非自闭症成人登记处建立了积极的合作伙伴关系,
我们将与传播和伙伴关系核心合作,加强对自闭症成人的包容
来自被边缘化的群体。临床核心组织了广泛的招募工作
确保项目达到其招生目标并完成其拟议的研究,同时确保所有
收集 ACE 资助机制规定的数据。这些服务集中在一个核心中
结合了本来会分配到各个项目的招聘资源,从而减少了
如果每个项目必须单独执行这些工作,就会出现冗余和低效率。
研究可靠的临床核心人员将使用这些工具进行 ASD 诊断和认知评估
RFA 中概述;这也创建了一个高效的流程并支持新研究人员的合作
ACE 中心的自闭症患者。最后,临床核心人员在评估 SI/SB 和
精神病学诊断并将监测与自杀相关的风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BENJAMIN L HANDEN其他文献
BENJAMIN L HANDEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BENJAMIN L HANDEN', 18)}}的其他基金
Mental Health in Autistic Adults: An RDoC Approach
成人自闭症患者的心理健康:RDoC 方法
- 批准号:
10523166 - 财政年份:2022
- 资助金额:
$ 54.15万 - 项目类别:
Mental Health in Autistic Adults: An RDoC Approach
成人自闭症患者的心理健康:RDoC 方法
- 批准号:
10523166 - 财政年份:2022
- 资助金额:
$ 54.15万 - 项目类别:
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)
阿尔茨海默病生物标志物联盟 - 唐氏综合症 (ABC-DS)
- 批准号:
10454470 - 财政年份:2020
- 资助金额:
$ 54.15万 - 项目类别:
相似国自然基金
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Phase I study of panobinostat in adults with sickle cell disease: novel approach to recruitment and retention
帕比司他治疗成人镰状细胞病的 I 期研究:招募和保留的新方法
- 批准号:
10420453 - 财政年份:2023
- 资助金额:
$ 54.15万 - 项目类别:
Organizational factors associated with quality of care for opioid use disorders among transition-age adults in Medicaid
与医疗补助中过渡年龄成人阿片类药物使用障碍护理质量相关的组织因素
- 批准号:
10563455 - 财政年份:2023
- 资助金额:
$ 54.15万 - 项目类别:
Transovarial transmission of yersinia pestis in fleas
跳蚤中鼠疫耶尔森氏菌的跨卵巢传播
- 批准号:
10727534 - 财政年份:2023
- 资助金额:
$ 54.15万 - 项目类别:
A Pilot of Memory Support System for Older Chinese Americans with Mild Cognitive Impairment
针对患有轻度认知障碍的老年华裔美国人的记忆支持系统试点
- 批准号:
10728571 - 财政年份:2023
- 资助金额:
$ 54.15万 - 项目类别:
A Randomized Clinical Trial of the Safety and FeasibiLity of Metformin as a Treatment for sepsis induced AKI (LiMiT AKI)
二甲双胍治疗脓毒症引起的 AKI (LiMiT AKI) 的安全性和可行性的随机临床试验
- 批准号:
10656829 - 财政年份:2023
- 资助金额:
$ 54.15万 - 项目类别: